Search

Change in Gastrointestinal Complaints After Switch From Oral Parkinson's Disease Treatment to Neupro® Transdermal Patch

Trial N/A Completed May 20, 2013

Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

Trial Phase 3 Completed May 19, 2013

Neuroimaging Studies of Depression in Parkinson's Disease

Trial N/A Completed May 16, 2013

Nicotine Treatment of Impulsivity in Parkinson's Disease

Trial Phase 4 Unknown May 13, 2013

Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin for the Treatment of Bilateral Idiopathic Parkinson's Disease

Trial Phase 1 Completed May 12, 2013

The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia

Trial Phase 3 Completed May 9, 2013

Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164

Trial Phase 3 Completed May 5, 2013

Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's Disease

Trial Phase 1 Completed April 30, 2013

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Apathy in Parkinson's Disease

Trial N/A Completed April 25, 2013

Pedunculo-Pontin Nucleus (PPN) - Deep Brain Stimulation (DBS) in Gait and Balance Disturbance in Parkinson's Disease (PPN-GAB-PARK Study)

Trial Phase 1 Unknown April 23, 2013

Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease

Trial Phase 2 Completed April 16, 2013

Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine

Trial N/A Completed April 14, 2013

Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease

Trial Phase 3 Completed April 11, 2013

Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease

Trial Phase 3 Completed April 11, 2013

A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease

Trial Phase 2 Completed March 28, 2013

A Study to Assess the Effect of Safinamide on Levodopa Pharmacokinetics

Trial Phase 1 Completed March 28, 2013

MOTION, Safinamide in Early Idiopathic Parkinson's Disease (IPD), as add-on to Dopamine Agonist (Extension of Trial 27918)

Trial Phase 3 Terminated March 28, 2013

Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects

Trial Phase 2 Completed March 28, 2013

Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa

Trial Phase 3 Completed March 28, 2013

Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease

Trial Phase 1 Withdrawn March 28, 2013